HIV Drug Resistance Program, NCI-Frederick, National Institutes of Health, Frederick, Maryland 21702, USA.
J Biol Chem. 2010 Jan 15;285(3):2100-12. doi: 10.1074/jbc.M109.030619. Epub 2009 Oct 15.
In this study, we identify determinants in dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) necessary for human immunodeficiency virus, type 1 (HIV-1), transmission. Although human B cell lines expressing DC-SIGN efficiently capture and transmit HIV-1 to susceptible target cells, cells expressing the related molecule liver/lymph node-specific ICAM-3-grabbing nonintegrin (L-SIGN) do not. To understand the differences between DC-SIGN and L-SIGN that affect HIV-1 interactions, we developed Raji B cell lines expressing different DC-SIGN/L-SIGN chimeras. Testing of the chimeras demonstrated that replacement of the DC-SIGN carbohydrate-recognition domain (CRD) with that of L-SIGN was sufficient to impair virus binding and prevent transmission. Conversely, the ability to bind and transmit HIV-1 was conferred to L-SIGN chimeras containing the DC-SIGN CRD. We identified Trp-258 in the DC-SIGN CRD to be essential for HIV-1 transmission. Although introduction of a K270W mutation at the same position in L-SIGN was insufficient for HIV-1 binding, an L-SIGN mutant molecule with K270W and a C-terminal DC-SIGN CRD subdomain transmitted HIV-1. These data suggest that DC-SIGN structural elements distinct from the oligosaccharide-binding site are required for HIV-1 glycoprotein selectivity.
在这项研究中,我们确定了树突状细胞特异性 ICAM-3 抓取非整联蛋白(DC-SIGN)中与人类免疫缺陷病毒 1 型(HIV-1)传播有关的决定因素。尽管表达 DC-SIGN 的人 B 细胞系能够有效捕获和将 HIV-1 转导至易感靶细胞,但表达相关分子肝/淋巴结特异性 ICAM-3 抓取非整联蛋白(L-SIGN)的细胞则不能。为了了解影响 HIV-1 相互作用的 DC-SIGN 和 L-SIGN 之间的差异,我们开发了表达不同 DC-SIGN/L-SIGN 嵌合体的 Raji B 细胞系。对嵌合体的测试表明,用 L-SIGN 替代 DC-SIGN 的碳水化合物识别域(CRD)足以损害病毒结合并阻止传播。相反,将 DC-SIGN CRD 赋予能够结合和转导 HIV-1 的 L-SIGN 嵌合体。我们确定 DC-SIGN CRD 中的色氨酸 258 对于 HIV-1 的传播是必需的。尽管在 L-SIGN 中相同位置引入 K270W 突变不足以结合 HIV-1,但具有 K270W 和 C 末端 DC-SIGN CRD 亚结构域的 L-SIGN 突变分子可以转导 HIV-1。这些数据表明,与寡糖结合位点不同的 DC-SIGN 结构元件对于 HIV-1 糖蛋白的选择性是必需的。